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Abstract
The misuse of antibiotics has been related to increased morbidity, mortality and bacterial resistance. The development of antimicrobial
stewardship programmes (ASPs) has been encouraged by scientific societies as an essential measure.An educational, institutionally
supported ASP was developed in our tertiary-care centre. Local guidelines on the management of infectious syndromes were created.
Antimicrobial prescriptions were chosen arbitrarily weekly and counselling interviews by expert clinicians were carried out, using a
paedagogic, non-restrictive methodology. Satisfaction with the interview was assessed using anonymous questionnaires. The appropri-
ateness of antimicrobial prescriptions as well as consumption was assessed prospectively throughout the year. Feedback regarding the
correct use of treatments was communicated to each participating department periodically. The improvement in antimicrobial prescription
was included among the annual objectives linked to economic incentives in every department.A total of 1206 counselling interviews were
carried out during the first year. Fifty-three per cent of antimicrobial prescriptions (176/332) were inappropriate when the programme
started. The rate of inappropriate prescriptions continuously declined to 26.4% (107/405) in the fourth trimester (p <0.001; RR = 0.38; 95%
CI, 0.23–0.43). Antimicrobial consumption decreased from 1150 defined daily doses (DDDs) per 1000 occupied bed-days in the first
trimester to 852 DDDs in the fourth, reflecting a reduction in antimicrobial expenditures of 42%. A total of 352 satisfaction questionnaires
were received and 98% described the advice as positive.In conclusion, the implementation of an education-based ASP achieved a significant
improvement in all antimicrobial prescriptions in the centre and a reduction in antimicrobial consumption, even when no restrictive
measures were implemented. The programme was highly accepted by all prescribers.
Keywords: Antibiotic usage, antimicrobial control policies, educational programmes
Original Submission: 12 October 2012; Revised Submission: 10 February 2013; Accepted: 10 February 2013
Editor M. Paul
Article published online: 27 February 2013
Clin Microbiol Infect 2014; 20: 82–88
10.1111/1469-0691.12191
Corresponding authors: J. M. Cisneros, Department of Infectious
Diseases, Microbiology and Preventive Medicine, Institute of
Biomedicine of Seville, IBiS, Hospital Universitario Virgen del Rocıo,
CSIC, University of Seville, Av. Manuel Siurot s/n, Seville 41012, Spain
E-mail: jmcisnerosh@gmail.com
J. Molina, Department of Infectious Diseases, Microbiology and
Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Hospital
Universitario Virgen del Rocıo, CSIC, University of Seville, Av. Manuel
Siurot s/n, Seville 41012, Spain
E-mail: josemolinagb@gmail.com
*Members of the PRIOAM team are listed in the Appendix.
Introduction
Over the last decade, an exponential increase in bacterial
resistance has been observed worldwide [1–4]. No new
antibacterial agents are expected to be on the market until
2018 at the earliest [5,6]. Furthermore, the overall societal
costs of antibiotic resistance were estimated to be 1.5 billion
€/year in the European Union [6]. Inappropriate use of
antibiotics has been shown to be directly related to the
increase of bacterial resistances [7], as well as to significant
increases in morbidity and mortality [8–10]. It is widespread in
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most health centres, and up to 50% of antibiotic treatments
prescribed have been estimated to be incorrect [11]. All
clinicians are potential antimicrobial prescribers; therefore the
generalization of antibiotic misuse is likely to be due to a
misbalance between the high level of knowledge required for
the appropriate use of antibiotics and the scarce training
offered in this respect to the practising clinician.
The development of antimicrobial stewardship programmes
(ASPs) in the hospital setting has been encouraged by scientific
societies worldwide [6,11–13], and they have proved to be an
essential measure in controlling bacterial resistance and
antibiotic expenditures [14].
An educational, institutionally supported ASP involving all
clinical departments has been developed in our tertiary-care
centre in order to improve the use of antimicrobial therapy
[15]. Here we present the results obtained during the first
year after its implementation.
Materials and Methods
Study period
The programme began on 1 January 2011. Data were
prospectively recorded during a 1-year period until the 31
December.
Setting
The programme was carried out in the Hospital Universitario
Virgen del Rocıo, in Seville (Spain), a 1251-bed tertiary care
teaching medical centre including 90 ICU beds and an active
solid-organ and hematopoietic stem-cell transplantation
programme. Until this program was designed, only pre-author-
ization formulary-restriction for imipenem, meropenem, er-
tapenem, colistin, sulbactam, tigecycline, vancomycin,
teicoplanin, linezolid, daptomycin, voriconazole, caspofungin,
mycafungin, anidulafungin and liposomal amphotericin existed
in our hospital and were accessible 24 h a day, including
weekends, with disappointing results.
In the national setting, no specific processes or guidelines
were established by January 2011, and this programme
constituted a pioneering experience in Spain. At the beginning
of 2012, a consensus document was published by several
national scientific societies in order to implement ASPs in
Spanish medical centres [13].
Institutional Programme for the Optimization of
Antimicrobial Treatment (PRIOAM)
Design and implementation.
.Step 1: Institutional agreements—PRIOAM is an initiative of the
local Committee of Hospital Infections and Antimicrobials. It
was designed as an institutional programme, whose objectives
were linked to economic incentives and formally accepted in
2011 by the Medical Directory Board and all clinical depart-
ments of the centre. The programme was approved by the
local ethical committee.
Step 2: Constitution of a multidisciplinary operations team—The
local Committee of Hospital Infections and Antimicrobials
constituted a team responsible for the programme implemen-
tation. It was coordinated by an infectious diseases (ID)
specialist and included a pharmacist, an intensive care and
preventive medicine specialist, a paediatrician and a microbi-
ologist, as well as an expert in clinical documentation.
Step 3: Elaboration of local guidelines—Sixty-four physicians from
different clinical departments, coordinated by the ID special-
ists, were asked to elaborate clinical guidelines for the use of
antimicrobials, adapted to the epidemiological situation of the
specific areas.
Step 4: PRIOAM implementation—The aim of the programme
and the clinical guidelines were presented and discussed
during clinical sessions in each clinical department of the
hospital. Guidelines were sent via e-mail to all physicians and
remained available on the intranet webpage of the hospital.
PRIOAM was included in the training programme for medical
residents.
Methodology. The main activity of the programme consists of a
training programme directed towards all antibiotic prescribers
in the centre based on counselling interviews (CIs). This
activity was carried out by a group of clinical experts who
were selected by the PRIOAM operations team, and included
seven ID specialists, six critical-care specialists and four
paediatricians. PRIOAM advisors were selected from local
leaders in the management of patients with infectious diseases
in each area. Each advisor conducted CIs in his/her area of
responsibility, concerning a specific antimicrobial treatment
randomly selected by the pharmacy service. The type of
treatment evaluated included perioperative prophylaxis,
empirical and targeted antimicrobial treatments. The number
of CIs scheduled for each clinical department was proportional
to its antimicrobial consumption. Departments with consump-
tion below 50 DDDs were assigned one CI per week,
departments with consumptions between 50 and 100 DDDs
were assigned two, and those with consumption beyond 100
DDD were assigned three CIs per week.
The CI was held with the physician responsible for the
antimicrobial prescription without prior warning of the
interview. The main objective of the counselling was to
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improve the prescribing skills of the interviewed physician
rather than to change the antimicrobial treatment. With this
aim, the advisor reviewed the antimicrobial treatment with
the prescriber, examined the patient’s clinical data and
discussed the main aspects of the prescribed treatment and
diagnosis of the infectious syndrome using a specific ques-
tionnaire (Appendix S1). Prescriptions were considered as
‘appropriate’ when all items of the questionnaire had been
accomplished correctly. If one or more of them were
incorrectly performed, the prescription was evaluated as
‘inappropriate’.
In order to homogenize recommendations, all advisors
employed the clinical guidelines previously elaborated, along
with the best available evidence. To reinforce this homogene-
ity, the PRIOAM team also coordinated monthly training
meetings with these advisors, which also served to monitor
the progress of the programme. The acceptance of the
programme was assessed using a voluntary anonymous
questionnaire, in which the opinion of the interviewed
clinicians regarding the usefulness of the CI was requested
(Appendix S2).
Evaluation and feedback of results. First year end-points: improve-
ment of antimicrobial prescription—The objective of improving
antimicrobial utilization was assessed with the CI (Appendix
S1) and considered to be achieved if a significant increase in CI
marks was recorded by the fourth trimester after the
implementation of the ASP. Evaluations were performed not
only for overall CI, but also specifically in each clinical
department. The trend in overall and specific antimicrobial
consumption, measured as number of DDDs/1000 occupied
bed-days, was also assessed during the same period. Only
antibiotics and antifungals were included. DDDs were calcu-
lated following the Anatomical Therapeutical Chemical Clas-
sification/Defined Daily Doses (ATC/DDD) methodology
recommended by the WHO. The indicators of this first
objective were evaluated 3-monthly; results were fed back to
the clinical departments and are presented here.
Statistical analysis
Normal distribution of the sample was assessed using the
Kolmogorov–Smirnov test. Paired categorical and continuous
variables were compared using the chi-squared test and Mann–
Whitney U-test, respectively. Significance was set at p <0.05.
Statistical analyses were performed with the PASW18.0
statistical package.
Results
A total of 1206 CIs were performed during the first year of the
programme. Advice was provided to 388 physicians from every
clinical department of the centre. The number of CIs per
clinical department was determined according to each depart-
ment’s antimicrobial consumption (Appendix S1). An average
of 3.1 CIs per physician was carried out. Interviews lasted
approximately, 10 min, the equivalent of 201 working hours
for the 1206 CIs.
The most frequently performed assessments were for
empirical prescriptions (52.2%, n = 630), followed by targeted
treatments (25.4%, n = 306) and surgical prophylaxis (22.4%,
n = 270). Among the different classes of antimicrobial agents
evaluated, cephalosporins were most commonly prescribed,
representing 20.8% of all CIs (n = 310), followed by glycopep-
tides, 11% (n = 164), and carbapenems, 10.1% CI (n = 150), as
seen in Appendix S2 (supplementary data file).
At the initiation of the programme, an overall rate of
inappropriate antimicrobial treatments of 53% was observed
(176 out of 332 CIs carried out during the first trimester). At
this point up to 56% of surgical prophylaxis, 55.2% of empirical
treatments and 46.6% of targeted treatments prescribed in the
centre were considered to be incorrect. Excessive duration of
TABLE 1. Evolution of the main causes of inappropriate antimicrobial treatment according to its indication
1st trimester
(% inappropriate
treatments)
2nd trimester
(% inappropriate
treatments)
3rd trimester
(% inappropriate
treatments)
4th trimester
(% inappropriate treatments) OR (IC95%)
Perioperative Prophylaxis 56 37.7 18.8 15.8a 0.34 (0.22–0.52)
Number of doses 54 26.3 12.5 7.5a 0.26 (0.13–0.51)
Administration timing 32 16.9 10.4 9.7a 0.51 (0.29–0.86)
Empirical treatment 55.1 45 33 33.3a 0.64 (0.52–0.78)
Microbiological samples collected 22.2 20.8 10.7 14.1a 0.7 (0.55–0.88)
Planned duration 17.1 10.8 6.8 5.6a 0.48 (0.29–0.78)
Inappropriate agent 19.6 21.8 11.8 13.1 0.78 (0.58–1.05)
Targeted treatment 46.6 40 18 21.6a 0.57 (0.42–0.76)
Not the most appropriate agent 25 24.6 16.4 9.3a 0.5 (0.29–0.89)
Treatment duration 22.7 13.3 4.9 5.2a 0.35 (0.15–0.77)
% inappropriate treatments indicates the rate of inappropriate prescriptions among all assessed treatments in each trimester.
aBold figures indicate comparisons between the first and fourth trimester that were statistically significant (for all of them p  0.05).
OR value indicates the proportional risk of inappropriate treatment for the fourth trimester compared with the first trimester.
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treatment was the most frequent error (52.8%), followed by
the choice of agent (38.6%). After the initiation of the
programme, inappropriate antimicrobial use overall, as well
as for each specific indication, decreased progressively
(Table 1). Antimicrobial consumption in the first trimester
was 1150 DDDs per 1000 occupied bed-days, and decreased
during the fourth trimester to 852 DDDs (Fig. 1). A decrease
was also observed when the consumption of specific classes of
agents was analysed (Fig. 2). This reduction implied an overall
decrease in direct antimicrobial expenditures of 42%; the 1
271 370 € costs recorded in the first trimester of 2011
progressively decreased to 1 104 649€, 952 519€ and
736 732€ during the following three trimesters. A 1 012 560
€ saving was estimated at the end of the year, assuming that
costs of the first trimester would have remained constant.
Economic and consumption data recorded in the first trimes-
ter of 2012 (800 DDDs; 741 703 €) confirm a sustained
reduction in pharmacy expenditures. This improvement was
not limited to specific units, because all departments improved
the rate of inappropriate treatments.
Three hundred and fifty-two satisfaction questionnaires
were recovered, reflecting 29.2% of all interviews carried out.
Ninety-eight per cent of them described the CI as useful.
Discussion
Our results demonstrate significant benefits of PRIOAM, an
institutional, education-based ASP 12 months after its imple-
mentation. The rate of appropriate treatments was improved
by 26.6%, whilst antimicrobial consumption decreased by 26%
and acceptance among clinicians was excellent.
Different approaches have been proposed previously for
implementing ASPs in the hospital setting, most of them
focused on an active limitation of the consumption of
broad-spectrum antibiotics [11,14]. However, restric-
tion-based strategies have shown variable results, because
programmes focusing on particular antibiotic agents may result
in increases in the use of alternative agents, which may
contribute to the spread of different mechanisms of resistance
[16–18]. Furthermore, narrower-spectrum antibiotics ideally
would need to be controlled, because all of them have been
shown to promote bacterial resistance [19,20]. Moreover,
restrictive measures could also be bypassed by clinicians to
assure the dispensation of restricted antibiotics [21], as
observed in our centre. Benefits due to the implementation
of an educational intervention in antibiotic control in the past
have been shown to be marginal [11] or limited to the control
of the use of very specific agents [18]. However, our results
have proven that an educational programme with an institu-
tional basis can be as effective as direct-control interventions.
This programme focused on the training of clinicians in the
sensitive use of antimicrobials, and thus was not exclusively
targeted towards broad-spectrum or expensive antibiotics.
Carbapenems and cephalosporins, agents traditionally included
in all antibiotic control programmes, represented only 30% of
all reviewed treatments, underlining the integral approach of
this ASP. The rate of appropriate treatments by the end of the
first year was superior to 75%, results that are similar to those
published for other audit-based programmes [22–24]. More-
over, not all stewardship programmes have shown significant
decreases in consumption [16,25,26], and some only achieved
FIG. 1. Decreasing rates of inappropriate antimicrobial use during
the first year of the programme.
1
trimester 
2
trimester 
3
trimester 
4
trimester 
Antibacterial 
Cephalosporins 
Quinolones 
Carbapenems 
Antifungal 
1048 814 762 811 
154.4 105.1 87.3 98.4 
146.8 108.9 96.4 105.7 
68 63.1 60.2 66.8 
102 46 32 41 
FIG. 2. Evolution of the consumption by class of antibiotics during
the first year of the programme, expressed in defined daily doses
(DDDs) per 1000 occupied bed-days.
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reductions attributed to specific agents, in the case of
antibiotic-targeted restrictive programmes [16,17]. Our pro-
gramme achieved an important decrease in all-class antimi-
crobial consumption by 26%, a favourable outcome compared
with other ASPs, which have reported reductions ranging from
4 to 22% [24,27,28]. The additional work burden for advisors
(10 min/interview) was low, supporting previous data on the
cost-effectiveness of ASPs [29].
Antibiotic consumption at the end of 2011 was recorded to
be 874.2 DDDs/1000 bed-days. This rate of consumption
places our hospital near the average of other tertiary Spanish
hospitals in 2009, reported to be 864 DDDs considering
antibiotics only, excluding the use of antifungals [30]. This
result is in favour of our centre, considering our noticeably
higher number of ICU beds (90 beds vs. a mean of 28 ICU beds
in other centres) and the especially active transplantation
programme.
The main strength of our programme lies in the
pedagogic approach. This form of intervention has been
the key to the programme’s success and its excellent level
of acceptance among interviewed clinicians. Aggressive audit
programmes may be less effective, and recommendations
may be rejected by prescribers [24,31], while voluntary,
recommendation-based counselling has been reported to
achieve excellent results [32]. In this sense, we consider the
involvement of local experts from all departments essential.
The use of an interactive methodology allowed the PRIOAM
team to define problems leading to antimicrobial misuse in
our centre, and to design specific programmes directed at
solving them. This has been the case for inadequate timing
of perioperative prophylaxis, the processing of microbiolog-
ical samples prior to the prescription of empirical treatment
and the planned treatment duration, which were the leading
causes of inappropriate prescribing. The novel elements
incorporated into this programme, ensuring its sustainability,
are its transversal design, the involvement of clinicians from
all departments, the low extra burden of work required to
implement the proposed pedagogic methodology in daily
clinical practice, and the strong institutional support, which
has linked the programme to economic incentives. Inter-
ventions to improve antibiotic prescribing to hospital
inpatients have been previously associated with reduced
antimicrobial resistance [14,28,33] and inappropriate antimi-
crobial treatment associated with increased morbidity and
mortality [8].
The main limitation of our analysis is the lack of assessment
of the clinical and epidemiological impact of the programme
during the first year. The evaluation of this is scheduled for
2013, 2 years after initiation of the programme, when the
clinical impact of this educational programme will reflect twice
the sample size of bacteraemia and incidence of hospital
microbial resistance.
Furthermore, a seasonal increase in antibiotic use could be
expected in the first trimester of the year, during the influenza
epidemic period, and thus the impact of the programme could
have been overrated. However, economic data recorded
during the same period of 2012 support a sustained reduction
in time, suggesting the observed changes to be attributable to
the ASP, and not to seasonal variations. Finally, our method-
ology does not fulfil all items required for a quasi-experimental
non-intervention study [34], because baseline information on
appropriate prescription previous to the programme is lacking.
Moreover, the impact of this programme, which is basically
educational, was expected to be very low during the 1 months
of its implementation. Altogether, we considered that the data
collected at the beginning of the programme were likely to be
an appropriate baseline.
The presented methodology and subsequent results dem-
onstrate that pedagogic educational programmes can be
effective in controlling global antibiotic misuse in a hospital.
The institutional support and the involvement of a multidis-
ciplinary team reveal a promising tool to maintain and to
continuously improve the appropriate use of antimicrobial
prescriptions achieved by this programme.
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